VECTIBIX

Описание товара

About VECTIBIX

VECTIBIX is a medication used in the treatment of certain types of cancer, specifically colorectal cancer. It contains the active ingredient PANITUMUMAB, a fully human monoclonal antibody that targets the epidermal growth factor receptor (EGFR). VECTIBIX is administered via intravenous infusion and is used to treat patients with wild-type KRAS metastatic colorectal cancer.

Key Benefits & Uses

• Treatment of metastatic colorectal cancer with wild-type KRAS
• Used in combination with chemotherapy for improved efficacy
• Targets and binds to the epidermal growth factor receptor (EGFR) to inhibit tumor growth

Active Ingredient & Action

PANITUMUMAB, the active ingredient in VECTIBIX, works by binding to the EGFR, preventing the receptor from interacting with its ligands. This interaction normally leads to cell division and the growth of new blood vessels that supply the tumor with nutrients. By blocking the EGFR, PANITUMUMAB inhibits the growth of cancer cells and induces apoptosis, or cell death.

Important Notes

VECTIBIX should only be administered under the supervision of a qualified healthcare professional. Patients should be monitored for potential side effects, including skin rash, hypomagnesemia, and infusion reactions. It is essential to follow the recommended dosage and administration guidelines to minimize the risk of adverse effects.